CN103126782B - A kind of Therapeutic Method of parasitic disease - Google Patents
A kind of Therapeutic Method of parasitic disease Download PDFInfo
- Publication number
- CN103126782B CN103126782B CN201310068047.7A CN201310068047A CN103126782B CN 103126782 B CN103126782 B CN 103126782B CN 201310068047 A CN201310068047 A CN 201310068047A CN 103126782 B CN103126782 B CN 103126782B
- Authority
- CN
- China
- Prior art keywords
- tricorn
- present
- needle
- therapeutic method
- parasitic disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention is applicable to Animal diseases treatment field, it is provided that the Therapeutic Method of a kind of parasitic disease, and described method includes: the empty needle pipe with sterilization syringe needle is extracted out the tricorn liquid of scheduled volume from tricorn;Extract described needle tubing, will be equipped with the syringe of 1ml medicine and connect described sterilization syringe needle, inject tricorn.The present invention is safe and reliable by the method treatment coenurosis of injectable drug, simple to operate, reduces cost, reduces brain injury and promotes success rate.
Description
Technical field
The invention belongs to Animal diseases treatment field, particularly relate to the Therapeutic Method of a kind of parasitic disease.
Background technology
Coenurosis is that the larva (coenurus) due to multiceps colonizes in and causes encephalitis, meningitis and a series of nervous symptoms in the brain of sheep, goat and cattle, spinal cord, and fatality rate is the parasitic disease of 100%.Coenurus sickness rate is generally 2%, is up to 58.3%.The whole nation there are about more than 300 ten thousand sheep every year and suffers from this and die of illness and die, it is seen that this disease extent of injury is significantly high.The operative therapy in the past adopted, after first finding affected part, cuts skin by operation requirement, cuts after skull extracts capsule liquid out and takes out encapsulation, last skin suture, wraps up wound.
Having some well suggestion and measures in recent years in prevention coenurosis, such as to the sheep suffering from coenurosis, the organ such as brain and spinal cord burns or buried, it is prevented that the carnivores such as dog search for food;To protecting the measures such as the sheep regular anthelmintic of dog.But pasture pollution is serious, it is impossible to thoroughly purify;In addition dog anthelmintic is paid little attention to or the factor such as anthelmintic is not thorough by some area so that coenurosis sickness rate remains high.Treatment concentration can be reached by blood brain barrier, so by intramuscular injection or oral insecticide, the invalid or poor efficiency to the polypide parasitized in cerebral tissue, the Therapeutic Method of surgical removal polypide can only be taked currently without anthelmintic drug.But surgical technic requires higher, often due to condition, equipment, the technical merit of operator and coenurus suffer from poultry brain the reasons such as many places infection same, postoperative sheep survival rate is caused to only have 40-50%.
Prior art, by the restriction of parasitic site, can only be done the coenurus polypide that superficial part is parasitic, for colonizing in the polypide in cerebral tissue deep, can not find polypide parasitic site, it is impossible to take out;Equally also by parasitic number quantitative limitation, generally can only extract the single polypide of infection, suffer from sheep to what infect two or more polypide, it is determined that position difficulty, success rate of operation is low;Prior art also by the restriction of parasitic time, can only in infecting, late period suffer from sheep and treat, suffer from sheep cannot perform the operation because not can determine that polypide position to infecting early stage.Once suffer from Medulla caprae seuovis tissue necrosis occurred by polypide compressing, success rate of operation is very low.
Summary of the invention
Embodiments provide the Therapeutic Method of a kind of parasitic disease, it is intended to solve prior art is difficult to determine the problem that the disease sites of coenurosis, success rate of operation are low and cost is high by operative treatment.
The embodiment of the present invention is achieved in that the Therapeutic Method of a kind of parasitic disease, and described method comprises the steps:
Empty needle pipe with sterilization syringe needle is extracted out from tricorn the tricorn liquid of scheduled volume;
Extract described needle tubing, will be equipped with the syringe of 1ml medicine and connect described sterilization syringe needle, inject tricorn.
The embodiment of the present invention is safe and reliable by the method treatment coenurosis of injectable drug, simple to operate, reduces cost, reduces brain injury and promotes success rate.
Accompanying drawing explanation
Fig. 1 represents the flowchart of the parasitic disease Therapeutic Method that first embodiment of the invention provides;
Fig. 2 represents the flowchart of the parasitic disease Therapeutic Method that second embodiment of the invention provides.
Detailed description of the invention
In order to make objects and advantages of the present invention clearly understand, below in conjunction with drawings and Examples, the present invention is further elaborated.Should be appreciated that specific embodiment described herein is only in order to explain the present invention, is not intended to limit the present invention.
The embodiment of the present invention, by choosing injection point, is extracted the tricorn liquid of scheduled volume out, and is injected the method treatment coenurosis of 1ml medicine with the electric drill with small size drill bit from animal tricorn.
What Fig. 1 illustrated the parasitic disease Therapeutic Method that first embodiment of the invention provides realizes flow process, and details are as follows:
In step S101 out, the empty needle pipe with sterilization syringe needle is extracted from tricorn the tricorn liquid of scheduled volume;
In an embodiment of the present invention, the tricorn liquid that the empty needle pipe with sterilization syringe needle extracts scheduled volume out from tricorn is specifically included:
1. being 2mm by diameter, the electric drill that the fixing exposed length of drill bit is 7mm proceeds to injection point, with sterilization syringe needle along boring thrust 2.5 centimetres deep, arrive tricorn;
In an embodiment of the present invention, electric drill is with being 7mm and adopt glue to emit or adhesive plaster is fastened drill bit from boring top to drilling rod.
As a preferred embodiment of the present invention, the injection point intersection line according to two basal part of the ear leading edges and trailing edge, it is injection point in cross point left or right 1.2 centimeters, and to injection site cropping, with iodine tincture, alcohol disinfecting.Such as: making intersection line respectively along sheep two basal part of the ear leading edge and two jiaos of root trailing edges, cross point (on cranium center line) is injection point to left or right 1.2 centimeters.According to mental symptom, analyze polypide substantially parasitic site, determine to take left or right intracerebroventricular, if skull has maceration, then select maceration to carry out injection effect better.
2. syringe needle accesses the tricorn liquid of 10ml empty needle pipe suction scheduled volume.
In an embodiment of the present invention, scheduled volume is 1 to 2ml, if namely amount of liquid much punctures coenurus parcel, is then taken out by its liquid to the greatest extent.
In step s 102, extract needle tubing, will be equipped with the syringe of 1ml medicine and connect sterilization syringe needle, inject tricorn.
In an embodiment of the present invention, medicine is add lytic agent, transdermal agent and stabilizer 1ml altogether in 0.2g praziquantel or add lytic agent, transdermal agent and stabilizer 1ml altogether in 0.1g albendazole, can according to animal size, physical condition, 0.5ml to 1.5ml medicine is all safe and effective dosage, and ordinary circumstance is administered about 1ml and is advisable.Praziquantel injection and two kinds of clinical drug experimental effects of albendazole injection are essentially identical, there was no significant difference, and owing to praziquantel injection physical property is more stable, are more conducive to clinical practice.
As a preferred embodiment of the present invention, extract needle tubing, will be equipped with the syringe of 1ml medicine and connect sterilization syringe needle, also include after injecting tricorn:
Transfer to syringe needle, seal pin hole with sulfanilamide and vaseline mixture.
What Fig. 2 illustrated the parasitic disease Therapeutic Method that second embodiment of the invention provides realizes flow process, and details are as follows:
In step s 201, selecting injection point, injection point is tricorn position or polypide parasitic site;
In step S202, being 2mm by diameter, the electric drill that the fixing exposed length of drill bit is 7mm proceeds to injection point;
In step S203, extract drill bit, access 10ml disposable syringe and extract tricorn liquid 1 to 2ml out 2.5 centimetres of depths or slowly take out most polypide hydatid cyst fluid;
In step S204, take off needle tubing and syringe needle stays put, will be equipped with the needle tubing of 1ml medicine and be connected on syringe needle, inject tricorn or polypide encapsulation;
Medicine is add lytic agent, transdermal agent and stabilizer 1ml altogether in 0.2g praziquantel or add lytic agent, transdermal agent and stabilizer 1ml altogether in 0.1g albendazole.
In step S205, extract syringe needle, with vaseline and the closure boring of sulfa powder mixture.
The embodiment of the present invention is safe and reliable by the method treatment coenurosis of injectable drug, simple to operate, reduces cost, reduces brain injury and promotes success rate.
The above is only the preferred embodiment of the present invention; it should be pointed out that, for those skilled in the art, under the premise without departing from the principles of the invention; can also making some improvements and modifications, these improvements and modifications also should be regarded as protection scope of the present invention.
Claims (1)
1. the medicine of a parasitic disease, it is characterized in that, described medicine is add lytic agent, transdermal agent and stabilizer 1ml altogether in 0.2g praziquantel or add lytic agent, transdermal agent and stabilizer 1ml altogether in 0.1g albendazole, use by injecting, after having injected, transfer to syringe needle, seal pin hole with sulfanilamide and vaseline mixture.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310068047.7A CN103126782B (en) | 2013-02-26 | 2013-02-26 | A kind of Therapeutic Method of parasitic disease |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310068047.7A CN103126782B (en) | 2013-02-26 | 2013-02-26 | A kind of Therapeutic Method of parasitic disease |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103126782A CN103126782A (en) | 2013-06-05 |
CN103126782B true CN103126782B (en) | 2016-06-29 |
Family
ID=48487674
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310068047.7A Expired - Fee Related CN103126782B (en) | 2013-02-26 | 2013-02-26 | A kind of Therapeutic Method of parasitic disease |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103126782B (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1246334A (en) * | 1998-08-31 | 2000-03-08 | 曾泳铭 | Drug for treating animal coccidiosis |
CN1533770A (en) * | 2003-03-26 | 2004-10-06 | 王玉万 | Saspension injection containing benzimidazole kind vermifuge |
CN101347406A (en) * | 2008-08-28 | 2009-01-21 | 成都乾坤动物药业有限公司 | Injection with high-content praziquantel and method of preparing the same |
CN102471341A (en) * | 2009-07-09 | 2012-05-23 | Irm责任有限公司 | Compounds and compositions for the treatment of parasitic diseases |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101926813B (en) * | 2009-06-25 | 2013-04-17 | 中国农业大学 | Veterinary compound anti-parasitic injection and preparation method thereof |
CN101984958B (en) * | 2010-11-01 | 2012-08-08 | 新疆医科大学第一附属医院 | Nanoscale albendazole micropowder and preparation method thereof |
-
2013
- 2013-02-26 CN CN201310068047.7A patent/CN103126782B/en not_active Expired - Fee Related
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1246334A (en) * | 1998-08-31 | 2000-03-08 | 曾泳铭 | Drug for treating animal coccidiosis |
CN1533770A (en) * | 2003-03-26 | 2004-10-06 | 王玉万 | Saspension injection containing benzimidazole kind vermifuge |
CN101347406A (en) * | 2008-08-28 | 2009-01-21 | 成都乾坤动物药业有限公司 | Injection with high-content praziquantel and method of preparing the same |
CN102471341A (en) * | 2009-07-09 | 2012-05-23 | Irm责任有限公司 | Compounds and compositions for the treatment of parasitic diseases |
Also Published As
Publication number | Publication date |
---|---|
CN103126782A (en) | 2013-06-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Quesenberry et al. | Basic approach to veterinary care | |
Ramsay | Felids | |
Vecchio et al. | Solitary subcutaneous hydatid cyst: review of the literature and report of a new case in the deltoid region | |
US20210008239A1 (en) | Medical Ozone Sterile Isotonic Saline Solution And Preparation Method And Application Thereof | |
Smith et al. | Pain management in small ruminants and camelids: applications and strategies | |
CN103126782B (en) | A kind of Therapeutic Method of parasitic disease | |
van den Hoogen et al. | Long term catheterization of the lumbar epidural space in rats | |
Gairhe | Veterinary care and breeding of elephants in Nepal | |
CN205814799U (en) | A kind of Special children syringe | |
EA201170319A1 (en) | APPENDIX SHIFT VOLTAGE FOR THE TREATMENT OF DISEASES | |
CN202620460U (en) | Nasal pharynx injector | |
CN208193186U (en) | Rat inflammation soup stimulates model | |
RU2613102C1 (en) | Method of increasing radioresistance in small cattle, subjected to ionizing radiation | |
Dechant | Complications of parenteral administration of drugs | |
US20150320964A1 (en) | Sterile liquid delivery system and method | |
CN209377708U (en) | A kind of inside can injection of medicine treatment Kirschner wire | |
CN202724444U (en) | Novel sterilization rod | |
CN203577006U (en) | Full-closed suction drug injecting system | |
Maji et al. | Surgical treatment of salivary fistula in a bullock. | |
Modu et al. | Chemotherapy and surgical treatment of penile and vaginal transmissible venereal tumor in mongrel dogs: Case report | |
Nistor et al. | The importance of drug therapy in lung multifocal hydatidosis | |
Bada et al. | Methods of treating ruminants’ diseases in veterinary hospital in Ado-Ekiti, Ekiti State | |
RU2350358C2 (en) | Method of increasing postinjection safety of medicines at repeated intramuscular injections | |
Taştekin et al. | Nicolau syndrome | |
RU2496530C2 (en) | Container syringe: device for storage and implantation of implantable personal identification code (chip) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20160629 Termination date: 20170226 |
|
CF01 | Termination of patent right due to non-payment of annual fee |